Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats

Indian Journal of Pharmacology

Volumn 42, Issue 6, 2010, Pages 384-387

  Najmi, Abul K ^a   Pillai, K K ^a   Pal, S N ^b   Akhtar, M ^a   Aqil, M ^a   Sharma, M ^a  

^a HAMDARD UNIVERSITY   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Hepatopathy; ornithine aspartate; oxidative stress; thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTATHIONE; ORNITHINE ASPARTATE; THIOACETAMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; LIVER DISEASE; LIVER FUNCTION; LIVER PROTECTION; NONHUMAN; RAT;

EID: 78149387568     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.71926     Document Type: Article

References (30)

1. Feher J, Lang I, Gogl A, Varga L, Tampos G, Pronia L. Effect of ornithine aspartate infusion on elevated serum ammonia concentration in cirrhotic patients- results of randomized placebo-controlled double blind multicentre trial. Med Sci Monit 1997;3:669-73.
2. Rose C, Michalak A, Pannunzio P, Therein G, Quack G, Kircheis G. L-ornithine- L-aspartate in experimental portal systemic encephalopathy: Therapeutic efficacy and mechanism of action. Metab Brain Dis 1998;13:147-57.
3. Butterworth RF. Hepatic encephalopathy. Neurologist 1995;1:95-104.
4. Jalan R, Shawcross D, Daveis N. The molecular pathogenesis of hepatic encephalopathy, Int J Biochem Cell Biol 2003;35:1175-81.
5. Meijer AJ, Lamers WH, Chamuleau RA. Nitrogen metabolism and ornithine cycle function, Physiol Rev 1990;70:701-48.
6. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Pomeir-Layrargues G. Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12.
7. Lizardi-Carvera L, Almeda P, Guevara L, Uribe M. Hepatic encephalopathy: A review. Ann Hepatol 2003;2:122-30.
8. Gebhardt R, Beckers G, Guanitz F, Haupt W, Jonitza D, Klein S. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels. J Pharmacol Exp Ther 1997;283:1-6.
9. Kircheis G, Wettstein M, Dahl S, Haussinger D. Clinical efficacy of l-ornithinel- aspartate in the management of hepatic encephalopathy. Metab Brain Dis 2002;17:453-62.
10. Jiang Q, Jiang XH, Zheng MH, Chen YP. l-ornitine-l-aspartate in the management of hepatic encephalopathy: A meta analysis. J Gastroenterol Hepatol 2009;24:9-14.
11. Sathyasaikumar KV, Swapna I, Reddy PV, Murthy CR, Roy KR, Gupta A, et al. Co-administration of C-Phycocyamin ameliorates thioacetamide induced hepatic encephalopathy in wistar rats. J Neurol Sci 2007;252:67-75.
12. Zarros A, Theocharis S, Skandali N, Tsakiris S. Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinestrase, Na(+), K(+)- and Mg(2+) -ATPase: Comparison of the enzymes response to in vitro treatment with ammonia. Metab Brain Dis 2008;23:255-64.
13. Reitman S, Frankel AS. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:53-6.
14. King PR, King EJ. Estimation of plasma phosphatase by determination of hydrolyzed phenol with amino antipyrine. J Clin Pathol 1954;7:322-6.
15. Varley H. Practical clinical Biochemistry. London: William Heinemann Medical books Ltd; 1980.
16. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959;82:70-7.
17. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animals tissues by thioabarbituric acid reaction. Anal Biochem 1979;95:351-8.
18. Lowry OH, Rosebrough NJ, Forr AL, Ramdall RJ. Protein measurement with the Folins phenol reagent. J Biol Chem 1951;193:265-75.
19. Luna LG. Manual of Histology, Staining Methods of Armed Forces Institute of Pathology. 3rd ed. New York: McGraw Hill Book Co; 1968.
20. Aftab A, Pillai KK, Najmi AK, Ahmad SJ, Pal SN, Balani DK. Evaluation of hepatoprotective potential of jigrine post treatment against thioacetamide induced hepatic damage. J Ethnopharmacol 2002;79:35-41.
21. Fitzhugh OG, Nelson AA. Liver tumours in rats fed thiourea or thioacetamide. Science 1948;108:626-8.
22. Barker EA, Smucklear EA. Non-hepatic thioacetamide injury, the morphological features of proximal tubular injury. Am J Pathol 1994;74:575-90.
23. Neal RA, Halpert J. Toxicity of thionosulfur compounds. Ann Rev Pharmcol Toxicol 1982;22:321-9.
24. Kumar G, Banu GS, Pappa PV, Sundararajan M, Pandian MR. Hepatoprotective activity of Trianthema portulacastum L. against paracetamol and thioacetamide intoxication in albino rats. J Ethnopharmacol 2004;92:37-40.
25. Perez MJ, Sanchez-Medina F, Torres M, Gil A, Saurez A. Dietary nucleotides enhance the liver redox state and protein synthesis in cirrhotic rats. J Nutr 2004;134:2504-8.
26. Torres-Lopez MI, Fernandez I, Gil A, Rios A. Influence of dietary nucleotide on liver structural recovery and hepatocyte binuclearity in cirrhosis induced by thioacetamide. Gut 1996;38:260-4.
27. Drotman RB, Lawhorn GT. Serum enzymes are indicators of chemical induced liver damage. Drug Chem Tox 1978;1:163-71.
28. Sinclair AJ, Barnett AH, Lunie J. Free radical and auto-oxidant systems in health and disease. J Appl Med 1991;17:409.
29. Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmuller E, Holm E. Effects of ornithine aspartate on plasma ammonia and amino acids in patients with cirrhosis. A double blind, randomized study using a four fold cross over design. J Hepatol 1993;19:424-30.
30. Abou-Assi S, Vlahsevic ZR. Hepatic encephalopathy: Metabolic consequence of cirrhosis often is reversible. Postgrad Med 2001;109:52-70.